Mentice Year-end Report Q4, Oct - Dec 2022
READ MORE
REGISTER
REGISTER FOR THE MENTICE YEAR-END REPORT Q4 OCT - DEC 2022 EARNINGS CALL
READ MORE
REGISTER

Mentice Investors

Our solutions help improve patient outcomes and clinical performance one therapy-one patient at a time.

Join CEO Göran Malmberg and CFO Gunilla Andersson as they present the company's Year-End Report Q4 2023. The live earnings call will be broadcasted on Friday 3rd, February at 10:00CET and followed by a Q&A moderated by Redeye's analyst Christian Binder.

To register and submit your questions, please visit:
https://www.redeye.se/events/870754/live-q-mentice

MNTC

Trading information
Short name for Nasdaq First North Growth Market : MNTC

ISIN-code: SE0012673291

The shares are registered by Euroclear Sweden AB

Advisor
FNCA Sweden AB is the Certified Advisor for the company

Important information about Nasdaq First North Growth Market Nasdaq
First North Growth Market is an alternate trading platform managed as a separate organization within NASDAQ Group. Companies listed on Nasdaq First North Growth Market is not managed under the same set of rules as the regulated main list market. The companies follow less complex set of rules and procedures adapted for small growth companies. The risk involved with investment in companies on First North Growth market can therefore be higher than investing in companies on the main market. All companies with shares that is traded on Nasdaq First North Growth Market has a certified advisor that secure and control that the rules are followed.


Dividends

The company has no history of Dividend.

Financial Calendar

26

October

2023

Q3 Interim Report JUL-SEP 2023

20

July

2023

Q2 Interim Report APR-JUN 2023

11

Maj

2023

Annual General Meeting 2023

27

April

2023

Q1 Interim Report JAN-MAR 2023

03

February

2023

Q4 Interim Report OCT-DEC 2022